VIVOS THERAPEUTICS INC (VVOS) Stock Overview
NASDAQ:VVOS - US92859E2072 - Common Stock
VVOS Key Statistics, Chart & Performance
The current stock price of VVOS is 4.2 USD. In the past month the price decreased by -19.85%. In the past year, price increased by 55.27%.
VVOS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.25 | 90.43B | ||
| CI | THE CIGNA GROUP | 10.83 | 81.24B | ||
| LH | LABCORP HOLDINGS INC | 18.37 | 23.12B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.05 | 20.15B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 116.22 | 15.23B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.61 | 15.02B | ||
| HIMS | HIMS & HERS HEALTH INC | 55.71 | 10.07B | ||
| DVA | DAVITA INC | 14.49 | 10.04B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.66B | ||
| CHE | CHEMED CORP | 20.52 | 6.69B | ||
| RDNT | RADNET INC | 194.72 | 5.39B | ||
| CRVL | CORVEL CORP | 50.9 | 4.75B |
Related stock screener links
About VVOS
Company Profile
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The company comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service, and others.
Company Info
VIVOS THERAPEUTICS INC
7921 Southpark Plaza,, Suite 210
Littleton COLORADO US
Employees: 113
Phone: 18669084867
VIVOS THERAPEUTICS INC / VVOS FAQ
What is the stock price of VIVOS THERAPEUTICS INC today?
The current stock price of VVOS is 4.2 USD. The price decreased by -8.7% in the last trading session.
What is the ticker symbol for VIVOS THERAPEUTICS INC stock?
The exchange symbol of VIVOS THERAPEUTICS INC is VVOS and it is listed on the Nasdaq exchange.
On which exchange is VVOS stock listed?
VVOS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VIVOS THERAPEUTICS INC stock?
8 analysts have analysed VVOS and the average price target is 4.31 USD. This implies a price increase of 2.61% is expected in the next year compared to the current price of 4.2. Check the VIVOS THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VIVOS THERAPEUTICS INC worth?
VIVOS THERAPEUTICS INC (VVOS) has a market capitalization of 28.22M USD. This makes VVOS a Nano Cap stock.
How many employees does VIVOS THERAPEUTICS INC have?
VIVOS THERAPEUTICS INC (VVOS) currently has 113 employees.
What are the support and resistance levels for VIVOS THERAPEUTICS INC (VVOS) stock?
VIVOS THERAPEUTICS INC (VVOS) has a support level at 4.1 and a resistance level at 4.43. Check the full technical report for a detailed analysis of VVOS support and resistance levels.
Is VIVOS THERAPEUTICS INC (VVOS) expected to grow?
The Revenue of VIVOS THERAPEUTICS INC (VVOS) is expected to grow by 0.64% in the next year. Check the estimates tab for more information on the VVOS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VIVOS THERAPEUTICS INC (VVOS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VVOS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VVOS, evaluating the profitability, health, valuation and growth aspects
- VIVOS THERAPEUTICS INC (VVOS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIVOS THERAPEUTICS INC (VVOS) Sales and EPS estimates to see what analysts future expectations are.
- VIVOS THERAPEUTICS INC (VVOS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIVOS THERAPEUTICS INC (VVOS) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIVOS THERAPEUTICS INC (VVOS) Stock Chart to make your own analysis
- VIVOS THERAPEUTICS INC (VVOS) Latest news and press-releases to stay up to date.
Does VIVOS THERAPEUTICS INC (VVOS) stock pay dividends?
VVOS does not pay a dividend.
When does VIVOS THERAPEUTICS INC (VVOS) report earnings?
VIVOS THERAPEUTICS INC (VVOS) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of VIVOS THERAPEUTICS INC (VVOS)?
VIVOS THERAPEUTICS INC (VVOS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.73).
What is the Short Interest ratio of VIVOS THERAPEUTICS INC (VVOS) stock?
The outstanding short interest for VIVOS THERAPEUTICS INC (VVOS) is 5.6% of its float. Check the ownership tab for more information on the VVOS short interest.
VVOS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to VVOS. When comparing the yearly performance of all stocks, VVOS is one of the better performing stocks in the market, outperforming 94.92% of all stocks.
VVOS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to VVOS. VVOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
VVOS Financial Highlights
Over the last trailing twelve months VVOS reported a non-GAAP Earnings per Share(EPS) of -1.73. The EPS increased by 83.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.6% | ||
| ROE | -254.98% | ||
| Debt/Equity | 0 |
VVOS Forecast & Estimates
8 analysts have analysed VVOS and the average price target is 4.31 USD. This implies a price increase of 2.61% is expected in the next year compared to the current price of 4.2.
For the next year, analysts expect an EPS growth of 46.02% and a revenue growth 0.64% for VVOS